Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe history now includes a new site revision (v3.7.0) replacing the previous revision (v3.6.6). This indicates a UI/system update rather than changes to the study record data.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.6 has been added to the Record History. This updates the page's version log and supersedes the previous v3.6.5 entry.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the study's record history, replacing Revision: v3.6.4. This indicates a software/interface update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check82 days agoChange DetectedNew revision label v3.6.4 was added to the study record history, replacing the previous v3.6.3. This indicates a minor update to the page history rather than a change to the study data or content.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.